Seres Therapeutics Stock (NASDAQ: MCRB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 53.55K / 4.88M |
Day Range | - - - |
52 Wk Range | 0.54 - 5.29 |
Market Cap | $142.51M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 21.11% |
Days to Cover | 3.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Seres Therapeutics (NASDAQ:MCRB) through any online brokerage.
Other companies in Seres Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and Lineage Cell Therapeutics (AMEX:LCTX).
There is no analysis for Seres Therapeutics.
Seres Therapeutics has a consensus price target of $8.78.
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $0.941 last updated Today at July 9, 2024 at 9:08 AM EDT.
There are no upcoming dividends for Seres Therapeutics.
Seres Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Seres Therapeutics.
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.